Robeco Institutional Asset Management B.V. Purchases New Stake in Omada Health, Inc. $OMDA

Key Points

• Robeco Institutional Asset Management purchased 52,844 Omada Health shares worth approximately $1.1 million, giving it a 0.09% stake. Several other institutional investors also initiated or increased positions.
• Omada insiders sold 127,642 shares valued at about $2.9 million during the last quarter, including sales by CEO Sean Duffy and President Wei-Li Shao.
• Analysts remain broadly positive, with a consensus “Moderate Buy” rating and a $26.67 price target. The company also beat quarterly estimates, reporting $0.08 EPS and $87.83 million in revenue.

Robeco Institutional Asset Management B.V. purchased a new stake in Omada Health, Inc. (NASDAQ:OMDA - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 52,844 shares of the company's stock, valued at approximately $1,100,000. Robeco Institutional Asset Management B.V. owned 0.09% of Omada Health as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of OMDA. Integrated Wealth Concepts LLC bought a new position in Omada Health in the 2nd quarter worth approximately $53,000. State of Alaska Department of Revenue purchased a new position in Omada Health in the 3rd quarter valued at approximately $59,000. Versant Capital Management Inc raised its holdings in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock valued at $66,000 after acquiring an additional 2,283 shares during the period. Legal & General Group Plc bought a new stake in Omada Health during the 2nd quarter valued at $76,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in shares of Omada Health during the second quarter worth $215,000.

Insider Transactions at Omada Health

In related news, CEO Sean Duffy sold 21,572 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $23.62, for a total value of $509,530.64. Following the sale, the chief executive officer owned 411,861 shares in the company, valued at approximately $9,728,156.82. This trade represents a 4.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, President Wei-Li Shao sold 8,866 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $25.02, for a total value of $221,827.32. Following the completion of the sale, the president owned 307,372 shares in the company, valued at $7,690,447.44. This trade represents a 2.80% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 127,642 shares of company stock valued at $2,915,201. 6.38% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

OMDA has been the subject of a number of analyst reports. JPMorgan Chase & Co. raised their price target on Omada Health from $26.00 to $30.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. Zacks Research upgraded Omada Health from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, October 6th. Citigroup reiterated an "outperform" rating on shares of Omada Health in a research note on Friday, August 14th. Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a report on Sunday, October 11th. Finally, BTIG Research restated a "buy" rating and issued a $35.00 target price on shares of Omada Health in a research note on Friday, September 11th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Omada Health has an average rating of "Moderate Buy" and a consensus target price of $26.67.

Omada Health Trading Up 1.5%

Omada Health stock opened at $19.24 on Tuesday. The firm's 50 day simple moving average is $21.13 and its 200 day simple moving average is $17.63. The firm has a market capitalization of $1.18 billion, a PE ratio of 236.88 and a beta of 2.03. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The firm had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. Research analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Omada Health Profile

Omada Health, Inc NASDAQ: OMDA is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines personalized health coaching, clinical support, behavioral-change tools and connected devices to help members monitor and improve their health.

The company's offerings focus primarily on cardiometabolic conditions, including diabetes, prediabetes, hypertension and obesity, as well as musculoskeletal conditions. Depending on the program, members may receive access to digital lessons, health tracking, remote monitoring, care teams and clinical guidance through Omada's technology platform.

Omada Health was founded in 2011 and serves employers, health plans and other healthcare organizations in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.